First FDA‑approved Longevity Drug Targets Dogs First
NEW Exclusive Interview: This miracle pill could make dogs live longer, with Celine Halioua, Founder & CEO of Loyal @celinehalioua is building the first drug ever FDA-approved for lifespan extension itself — starting with dogs. We sat down on Onward to talk about why she thinks longevity is the most under-built frontier in medicine and what’s next for @loyalfordogs. We cover: Why the U.S. healthcare system structurally can't build preventative medicine The "micro single-payer" reason dogs are the perfect first market "Save the dogs, save the world" — Loyal's Tesla-style master plan The September 2019 FDA pathway change that made the entire company possible Why big dogs die young (growth hormones that never turn off) Caloric restriction mimetics — the second drug, for dogs of any size Why drug development is mostly logistics and economics, not science Scenario planning the next five years of biotech Why Loyal is AI-resistant and AI-amplified Being fired (and rehired) from the longevity fund — twice Bottom 10% of her high school class → Oxford → dropping out six months from her PhD Watch the full episode below → 𝐓𝐈𝐌𝐄𝐒𝐓𝐀𝐌𝐏𝐒 (00:00) Celine Halioua, Founder & CEO of Loyal (01:36) What is Loyal? (02:29) Why big dogs die younger (05:47) How the second drug works (08:22) First longevity drug in history (09:37) Why longevity drugs never existed (16:13) The master plan (18:23) Private vs Public (20:00) Three steps to market (25:55) The regulatory loophole (29:27) Scenario planning (31:54) AI and drug development (35:42) Good scenario (38:03) Bad scenario (39:35) Unexpected scenario (44:06) Why Fundrise (49:27) Founding story
AI Pushes Total Data Capture for Insight and Automation
AI wants us to record everything in the world. More data = more insights = more automation
10% Better Decisions Could Transform Our Lives
What if everyone made 10% better decisions? AI will improve every decision we make: - personal finance - health - career - relationships - management Imagine the improvement in well being and growth
Maydan Anchors West Jefferson's Transformation After Six Years
More than 6 years ago, @fundrise began developing 18 buildings in West Jefferson, Los Angeles. Our anchor project is Maydan, which we believe will help catalyze the neighborhood. It is unbelievably gratifying to see it come together so well. https://t.co/WAN0UTcG5q https://t.co/cDZ1eQcsK6
BTR May Be History’s Worst Low‑Density Rebrand
Will “build-to-rent” (BTR) go down in history as the worst rebranding of low-density apartment development?
BTR Ban Strips Safety Net, Halting Risky Land Development
Over the past 2 years, we’ve owned and developed 10,000 housing lots in “for-sale” housing. Everyone is thinking about it like building a single house, but the typical development is 20-50 acres for a community of hundreds of new homes. The biggest...
Oppose 21st Century ROAD Act: It Hinders Build‑to‑Rent
Please voice your opposition to the 21st Century ROAD to Housing Act, which as currently drafted punishes new Build-to-Rent housing construction. https://t.co/gYsrYfSiJu https://t.co/WLqgU46iDQ